Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2386]

FDA approves first line treatment for peripheral T-cell lymphoma under new review pilot

FDA approves first line treatment for peripheral T-cell lymphoma under new review pilot

Osteopontin: A new emerging role in HCV-related hepatocellular carcinoma

Osteopontin: A new emerging role in HCV-related hepatocellular carcinoma

First blood based biomarker in response to the treatment of the most aggressive prostate cancer

First blood based biomarker in response to the treatment of the most aggressive prostate cancer

The evolution of advanced melanoma treatment: is long-term survivorship on the horizon?

The evolution of advanced melanoma treatment: is long-term survivorship on the horizon?

Faecal transplant effective against immunotherapy-induced colitis

Faecal transplant effective against immunotherapy-induced colitis

Obesity both feeds tumours and helps immunotherapy kill cancer

Obesity both feeds tumours and helps immunotherapy kill cancer

Spectrum of cardiovascular toxicities with immune checkpoint inhibitors revealed

Spectrum of cardiovascular toxicities with immune checkpoint inhibitors revealed

The evolution of advanced melanoma treatment: is long-term survivorship on the horizon?

The evolution of advanced melanoma treatment: is long-term survivorship on the horizon?

Small populations of normal cells affect immunity in patients with XLP1

Small populations of normal cells affect immunity in patients with XLP1

Combination chemotherapy and immunotherapy effective in Phase II leukaemia study

Combination chemotherapy and immunotherapy effective in Phase II leukaemia study

More from ecancer